BKYI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BKYI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. BIO-key International's annualized ROCE % for the quarter that ended in Sep. 2023 was -58.99%.
The historical data trend for BIO-key International's ROCE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BIO-key International's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:
ROCE % | = | EBIT | / | ( (Capital Employed | + | Capital Employed) | / count ) |
(A: Dec. 2022 ) | (A: Dec. 2021 ) | (A: Dec. 2022 ) | |||||
= | EBIT | / | ( ( (Total Assets - Total Current Liabilities) | + | (Total Assets - Total Current Liabilities) ) | / count ) | |
(A: Dec. 2022 ) | (A: Dec. 2021 ) | (A: Dec. 2022 ) | |||||
= | -11.92 | / | ( ( (17.769 - 1.999) | + | (11.344 - 5.456) ) | / 2 ) | |
= | -11.92 | / | ( (15.77 | + | 5.888) | / 2 ) | |
= | -11.92 | / | 10.829 | ||||
= | -110.07 % |
BIO-key International's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:
ROCE % | = | EBIT (1) | / | ( (Capital Employed | + | Capital Employed) | / count ) |
(Q: Sep. 2023 ) | (Q: Jun. 2023 ) | (Q: Sep. 2023 ) | |||||
= | EBIT | / | ( ( (Total Assets - Total Current Liabilities) | + | (Total Assets - Total Current Liabilities) ) | / count ) | |
(Q: Sep. 2023 ) | (Q: Jun. 2023 ) | (Q: Sep. 2023 ) | |||||
= | -2.368 | / | ( ( (10.583 - 6.276) | + | (9.749 - 6.028) ) | / 2 ) | |
= | -2.368 | / | ( ( 4.307 | + | 3.721 ) | / 2 ) | |
= | -2.368 | / | 4.014 | ||||
= | -58.99 % |
(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BIO-key International (NAS:BKYI) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
Thank you for viewing the detailed overview of BIO-key International's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.
Michael W Depasquale | director, officer: Co-Chief Executive Officer | 1285 CORPORATE CENTER DR, STE 175, EAGAN MN 55121 |
James David Sullivan | officer: See Remarks | 411 WALNUT ST., PMB #15855, GREEN COVE SPRINGS FL 32043 |
Cameron E. Williams | director | 400 N. CASCADES CIRCLE, CANTON GA 30114 |
Fong Wong Kwok | director | FLAT C, 27/F., BLOCK 5, GRAND PACIFIC VIEWS, SIU LAM K3 00000 |
Emmanuel Alia | director | 15 C SIGNAL HILL ROAD, MADISON CT 06443 |
Robert J Michel | director | C/O ASTA FUNDING, INC., 210 SYLVAN AVENUE, ENGLEWOOD CLIFFS NJ 07632 |
Micron Technology Development Ltd | 10 percent owner | 5/F., SPA CENTRE, 53-55 LOCKHART ROAD, WANCHAI K3 999077 |
Yick Fabian Shin | director | FLAT B, 23/F, TOWER 2B, 19 TONG YON ST.,, THE WINGS IIIA, TSEUNG KWAN O., NEW TERRITORIES K3 00000 |
Knook Pieter Cornelis | director | 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719 |
Jianhui Yao | director | SUITES 2601-2, 26/F TOWER 2, NINA TOWER, 8 YEUNG UK RD, TSUEN WAN K3 TWTL 353 |
Barbara Rivera | director | C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719 |
Thomas Gilley | director | C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719 |
Iii Thomas Bush, | director | C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719 |
Cecilia C Welch | officer: Chief Financial Officer | PO BOX 588, DUNSTABLE MA 01827 |
John Schoenherr | director | C/O ORACLE CORPORATION, 10 VAN DE GRAAFF DRIVE, BURLINGTON MA 01803 |
From GuruFocus
By sperokesalga 06-20-2023
By sperokesalga 06-05-2023
By sperokesalga 05-16-2023
By sperokesalga 05-30-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.